FdaApplication
NDA 214278
Identifiers
- fda_app_no: NDA214278
Properties
| Property | Value |
|---|---|
| applicant_name | DEXCEL PHARMA TECHNOLOGIES LTD |
| application_type | NDA |
| approval_date | 2020-10-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL |
1 product